Oaktree Specialty Lending (OCSL) Stock Forecast, Price & News

Oaktree Specialty Lending (NASDAQ:OCSL) Frequently Asked Questions

Is Oaktree Specialty Lending a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Oaktree Specialty Lending in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Oaktree Specialty Lending stock.
View analyst ratings for Oaktree Specialty Lending or view top-rated stocks.

When is Oaktree Specialty Lending's next earnings date?

Oaktree Specialty Lending is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Oaktree Specialty Lending.

How were Oaktree Specialty Lending's earnings last quarter?

Oaktree Specialty Lending Co. (NASDAQ:OCSL) announced its earnings results on Thursday, May, 5th. The credit services provider reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.01. The credit services provider had revenue of $64.30 million for the quarter, compared to the consensus estimate of $58.95 million. Oaktree Specialty Lending had a trailing twelve-month return on equity of 9.59% and a net margin of 53.18%.
View Oaktree Specialty Lending's earnings history.

How often does Oaktree Specialty Lending pay dividends? What is the dividend yield for Oaktree Specialty Lending?

Oaktree Specialty Lending declared a quarterly dividend on Thursday, May 5th. Stockholders of record on Wednesday, June 15th will be given a dividend of $0.165 per share on Thursday, June 30th. This represents a $0.66 dividend on an annualized basis and a dividend yield of 9.82%. The ex-dividend date of this dividend is Tuesday, June 14th. This is an increase from Oaktree Specialty Lending's previous quarterly dividend of $0.16.
View Oaktree Specialty Lending's dividend history.

Is Oaktree Specialty Lending a good dividend stock?

Oaktree Specialty Lending pays an annual dividend of $0.64 per share and currently has a dividend yield of 9.30%. OCSL has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Oaktree Specialty Lending has been increasing its dividend for 3 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of Oaktree Specialty Lending is 84.21%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, Oaktree Specialty Lending will have a dividend payout ratio of 91.43% in the coming year. This indicates that Oaktree Specialty Lending may not be able to sustain their current dividend.
View Oaktree Specialty Lending's dividend history.

What price target have analysts set for OCSL?

2 brokers have issued 12-month price targets for Oaktree Specialty Lending's shares. Their forecasts range from $7.00 to $8.50. On average, they expect Oaktree Specialty Lending's stock price to reach $7.67 in the next year. This suggests a possible upside of 14.1% from the stock's current price.
View analysts' price targets for Oaktree Specialty Lending or view top-rated stocks among Wall Street analysts.

Who are Oaktree Specialty Lending's key executives?

Oaktree Specialty Lending's management team includes the following people:

• Mr. Armen Panossian J.D., CEO & Chief Investment Officer (Age 45)
• Mr. Mathew M. Pendo, Pres (Age 58)
• Mr. Christopher McKown, MD, CFO & Treasurer (Age 40)
• Mr. Matthew Stewart C.F.A., CPA, CFA, CPA, Sr. VP & COO (Age 37)
• Mr. Emil O. Caliboso, Accounting Supervisor
• Mr. Michael Mosticchio, Investor Relations
• Ms. Ashley Pak, Chief Compliance Officer (Age 44)
• Mr. Sandeep Kumar Khorana, Managing Director of Origination (Age 49)
• Mr. Brian D. Finkelstein, Managing Director
• Mr. Gregory M. Browne, Managing Director of Healthcare Leveraged Fin. Origination

Who are some of Oaktree Specialty Lending's key competitors?

Some companies that are related to Oaktree Specialty Lending include BlackRock (BLK), Bank of New York Mellon (BK), Ameriprise Financial (AMP), T. Rowe Price Group (TROW), State Street (STT), Northern Trust (NTRS), Franklin Resources (BEN), Ares Capital (ARCC), Invesco (IVZ), SEI Investments (SEIC), Affiliated Managers Group (AMG), Cohen & Steers (CNS), Prospect Capital (PSEC), Main Street Capital (MAIN) and Golub Capital BDC (GBDC).
View all of OCSL's competitors.

What other stocks do shareholders of Oaktree Specialty Lending own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oaktree Specialty Lending investors own include Prospect Capital (PSEC), Energy Transfer (ET), AGNC Investment (AGNC), Annaly Capital Management (NLY), Ready Capital (RC), Ares Capital (ARCC), AT&T (T), PennantPark Investment (PNNT), PhenixFIN (MCC) and New Residential Investment (NRZ).

What is Oaktree Specialty Lending's stock symbol?

Oaktree Specialty Lending trades on the NASDAQ under the ticker symbol "OCSL."

Who are Oaktree Specialty Lending's major shareholders?

Oaktree Specialty Lending's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Ares Management LLC (2.68%), Bruni J V & Co. Co. (2.50%), Van ECK Associates Corp (2.14%), Private Management Group Inc. (2.02%), LSV Asset Management (1.70%) and CLARET ASSET MANAGEMENT Corp (1.63%). Company insiders that own Oaktree Specialty Lending stock include Armen Panossian, Ashley Pak, Deborah Ann Gero, Leonard M Tannenbaum, Leonard M Tannenbaum, Mathew Pendo, Phyllis R Caldwell and Richard Ruben.
View institutional ownership trends for Oaktree Specialty Lending.

Which major investors are selling Oaktree Specialty Lending stock?

OCSL stock was sold by a variety of institutional investors in the last quarter, including Private Management Group Inc., Rivernorth Capital Management LLC, TCW Group Inc., Ares Management LLC, Raymond James & Associates, abrdn plc, Mackenzie Financial Corp, and UBS Group AG.
View insider buying and selling activity for Oaktree Specialty Lending or view top insider-selling stocks.

Which major investors are buying Oaktree Specialty Lending stock?

OCSL stock was acquired by a variety of institutional investors in the last quarter, including Van ECK Associates Corp, Royal Bank of Canada, First Republic Investment Management Inc., Waverton Investment Management Ltd, LSV Asset Management, Qube Research & Technologies Ltd, Cliffwater LLC, and Rezny Wealth Management Inc.. Company insiders that have bought Oaktree Specialty Lending stock in the last two years include Armen Panossian, Ashley Pak, Deborah Ann Gero, Mathew Pendo, Phyllis R Caldwell, and Richard Ruben.
View insider buying and selling activity for Oaktree Specialty Lending or or view top insider-buying stocks.

How do I buy shares of Oaktree Specialty Lending?

Shares of OCSL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Oaktree Specialty Lending's stock price today?

One share of OCSL stock can currently be purchased for approximately $6.72.

How much money does Oaktree Specialty Lending make?

Oaktree Specialty Lending has a market capitalization of $1.23 billion and generates $209.38 million in revenue each year. The credit services provider earns $237.26 million in net income (profit) each year or $0.759990 on an earnings per share basis.

What is Oaktree Specialty Lending's official website?

The official website for Oaktree Specialty Lending is www.oaktreespecialtylending.com.

How can I contact Oaktree Specialty Lending?

Oaktree Specialty Lending's mailing address is 333 SOUTH GRAND AVENUE 28TH FLOOR, LOS ANGELES CA, 90071. The credit services provider can be reached via phone at (213) 830-6300, via email at [email protected], or via fax at 203-681-3879.